Landfar Bio-medicine Co., Ltd (SHE:000504)
China · Delayed Price · Currency is CNY 8.18
-0.08 (-0.97%)
Nov 6, 2026, 10:25 AM CST
Landfar Bio-medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 309.9 | 346.77 | 207.36 | 493.81 | 218.15 | 153 |
Trading Asset Securities | - | - | 0.61 | 1.72 | 1.69 | 0.5 |
Cash & Short-Term Investments | 309.9 | 346.77 | 207.97 | 495.53 | 219.83 | 153.51 |
Cash Growth | 17.71% | 66.74% | -58.03% | 125.41% | 43.21% | 126.76% |
Accounts Receivable | 170.94 | 320.48 | 139.58 | 123.22 | 158.76 | 197.92 |
Other Receivables | 18.15 | 18.02 | 4.39 | 19.35 | 27.67 | 8.82 |
Receivables | 189.09 | 338.5 | 143.98 | 142.57 | 186.43 | 206.74 |
Inventory | 19.13 | 18.67 | 34.06 | 10.66 | 4.5 | 10.64 |
Prepaid Expenses | - | - | 0.16 | 0.07 | 0.03 | 0.57 |
Other Current Assets | 51.17 | 34.99 | 15.74 | 6.02 | 5.44 | 145.17 |
Total Current Assets | 569.29 | 738.92 | 401.9 | 654.85 | 416.24 | 516.62 |
Property, Plant & Equipment | 165.17 | 170.22 | 26.05 | 28.06 | 35.93 | 35.85 |
Long-Term Investments | - | - | 100 | 5.42 | 5.48 | 5.98 |
Goodwill | 6.23 | 6.23 | 1.98 | 1.98 | 8.44 | 8.44 |
Other Intangible Assets | 53.33 | 55.81 | 1.86 | 0.44 | 0.36 | 0.22 |
Long-Term Accounts Receivable | - | - | 0.03 | 0.04 | 0.06 | 0.07 |
Long-Term Deferred Tax Assets | 12.15 | 8.71 | 1.92 | 1.11 | 0.6 | 1.05 |
Long-Term Deferred Charges | 7.78 | 10.83 | 73.75 | 79.48 | 85.67 | 89.58 |
Other Long-Term Assets | 0.7 | 1.01 | 0.67 | - | 0.58 | 1.44 |
Total Assets | 814.64 | 991.73 | 608.17 | 771.38 | 553.37 | 659.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 15.56 | 14.72 | 84.47 | 82.21 | 82.03 | 89.56 |
Accrued Expenses | 2.58 | 21.35 | 10.85 | 9.01 | 8.61 | 6.17 |
Short-Term Debt | 127.29 | 270.25 | - | 187.71 | 218.73 | 293.06 |
Current Portion of Long-Term Debt | 6.01 | 12.09 | 1 | - | - | - |
Current Portion of Leases | - | 2.71 | 3.61 | 3.16 | 2.81 | 2.35 |
Current Income Taxes Payable | 1.62 | 2.5 | 2.58 | 1.62 | 7.19 | 4.88 |
Current Unearned Revenue | 206.02 | 201.45 | 185.18 | 151.41 | 119.74 | 123.84 |
Other Current Liabilities | 16.85 | 20.09 | 17.79 | 17.28 | 16.04 | 9.14 |
Total Current Liabilities | 375.93 | 545.16 | 305.47 | 452.4 | 455.15 | 529 |
Long-Term Debt | 52.95 | 52.95 | 9 | - | - | - |
Long-Term Leases | 4.09 | 3.24 | 10.45 | 13 | 14.79 | 16.89 |
Long-Term Unearned Revenue | 32.56 | 26.64 | 1.1 | 1.06 | 1.83 | 1.4 |
Long-Term Deferred Tax Liabilities | 5.77 | 6.24 | 0.15 | 0.25 | 0.41 | 0.64 |
Other Long-Term Liabilities | - | - | - | - | 1 | 1 |
Total Liabilities | 471.29 | 634.22 | 326.17 | 466.71 | 473.18 | 548.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 330.02 | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 |
Additional Paid-In Capital | 423.3 | 423.3 | 423.47 | 423.47 | 170.82 | 160.99 |
Retained Earnings | -489.82 | -487.57 | -516.4 | -496.55 | -468.38 | -455.92 |
Total Common Equity | 263.5 | 265.75 | 237.1 | 256.94 | 14.01 | 16.64 |
Minority Interest | 79.84 | 91.76 | 44.9 | 47.73 | 66.18 | 93.68 |
Shareholders' Equity | 343.34 | 357.51 | 282 | 304.67 | 80.19 | 110.32 |
Total Liabilities & Equity | 814.64 | 991.73 | 608.17 | 771.38 | 553.37 | 659.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | 190.34 | 341.24 | 24.06 | 203.87 | 236.33 | 312.29 |
Net Cash (Debt) | 119.56 | 5.53 | 183.91 | 291.66 | -16.5 | -158.79 |
Net Cash Growth | -10.44% | -97.00% | -36.94% | - | - | - |
Net Cash Per Share | 0.37 | 0.02 | 0.56 | 0.93 | -0.05 | -0.50 |
Filing Date Shares Outstanding | 334.07 | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 |
Total Common Shares Outstanding | 334.07 | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 |
Working Capital | 193.36 | 193.76 | 96.43 | 202.45 | -38.92 | -12.38 |
Book Value Per Share | 0.79 | 0.81 | 0.72 | 0.78 | 0.04 | 0.05 |
Tangible Book Value | 203.95 | 203.71 | 233.25 | 254.52 | 5.21 | 7.98 |
Tangible Book Value Per Share | 0.61 | 0.62 | 0.71 | 0.77 | 0.02 | 0.03 |
Buildings | - | 80.54 | - | - | 12.94 | 12.94 |
Machinery | - | 108.15 | 25.09 | 23.4 | 22.39 | 16.85 |
Construction In Progress | - | 0.11 | - | - | - | 1.29 |